Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What, why and when are the questions of the day.
No real news for a long time now.
Still here and waiting.
This baby better to start speaking in a real language and soon or it will be dad.
Doc, if MMs knew that you would be so happy they would put another 100k shares in for you. How come you all believe in 28 of July cutoff day? Any reason to believe in Medify's promises? Don't get so excited!
Bax, you said it all.
Yes, Ann is bright, as for Hillary not sure. As for Jonathan we
will see pretty soon now.
Will you take 38%? You have no choice.
Ann... Guys, what do you see in her? IMHO.
I'm planning to buy a house there. GO RSHN!!!
Wishful thinking...
Future Extraordinary dividend is moving MFYS in Extraordinary way by now.
Should be plenty to report by now. What is holding them?
Herbie, my understanding is that Stocktargets are way below than projected by Jonathan. We shall see.
StockTargets Red Alert
Major Development for Small Cap Company
July 19th, 2006
Medify Solutions Ltd.
Special Situation
Symbol:
MFYS (.pk)
Last Trade:
$ 0.06
Yesterday's Change:
up by $ 0.01
Consensus 1 Year Target:
$ 1.41
1 Year Analyst Target Price:
$ 1.96
6 Months Target:
$ 0.90
!! Extraordinary Dividend Announced!!
The Dividend is worth as much as the
Stock itself !
!! We expect the stock to double by July 28th !!
Well, this is how I look at the numbers:
If divedend goes at $ 1+ so MFYS should be trading around this price too because of benefits from Europe and potentially some other dividends coming. So Clancy's numbers may be doubled as well. IMHO
Not this Clancy. Something else. Any takers?
Press Release Source: Medify Solutions Ltd.
Medify Solutions Ltd (Pink Sheets: MFYS) extraordinary dividend eligibility closes on Friday 28th July, 2006
Wednesday July 19, 9:45 am ET
TORONTO, July 19 /PRNewswire-FirstCall/ - The board of Medify Solutions Limited has announced the confirmation of the extraordinary share dividend following its European subsidiary float. As stated, all shareholders in Medify Solutions Limited (Pink Sheets: MFYS - News) will receive a share for share dividend granted on floatation.
For every share held in Medify Solutions Limited, existing share holders will receive a reciprocal free trading share in the European operation. Eligibility for this dividend is valid for all shareholders and closes at the close of the market on Friday 28th July 2006.
Jonathan Bryant, Executive Chairman, said: "The announcement of the closing date for eligibility for the shareholders' extraordinary dividend is a clear mark of intent and a demonstration of the progress of the company. I hope all Medify shareholders will take confidence in this announcement and look forward to the future and the success of Medify, now on a global basis."
He added: "I congratulate the team for making this a reality and we as shareholders should be extremely excited about this confirmation. The plans, the vision and the success are now becoming the reality for the Medify Group of companies. I believe these will prove to be exciting and profitable times for anyone associated with Medify especially those who have a shareholding."
Every share held by a shareholder at the closing of the market on Friday July 28th 2006 will be entitled to the extraordinary dividend.
Medify Solutions Inc. (Pink Sheets: MFYS - News) is the first business to have developed a Secure Remote Access product, addressing critical requirements of the UK National Health Service, and many other medical computer systems, bringing the latest flexible integrated wireless and web-based technologies for healthcare revision. MedifyRemote, its leading product, is an application that allows remote access to a patient's record through a Pocket PC. This solution is not specific to any single clinical data system, but applicable to all the NHS /Healthcare software systems in any healthcare market. The company's website is http://www.medifysolutions.com.
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
--------------------------------------------------------------------------------
Source: Medify Solutions Ltd.
Clancy, your numbers are not quite correct. Who knows why?
Jstellar, I think you are way too conservative. With any of these good news we could top 1c.
Sorry LLoyd, wasn't worring about exit stragegy on this as much as staying on the side and watching before got kicked in the butt by Japanese. Got mine 6 mill lesson myself.
On Medify issue I'm standing just where you are. Good luck.
LLoyd, this exact philosophy this country used to have before WW2. The rest is history. Study it.
Thank you, Purple.
Thank you, Herbie! My best wishes to you too.
Also I got response from JB which is similar to other.
My BD passed on w/o any present from JB. O well, the dreams we dream. Good luck to all and good health!
Doc, I guess another great bying opportunity for SVMI, 46% down?
Don't be so gloomy. Not crying just waiting and still holding strong!
Hold on. I have a strong feeling that next week is THE WEEK.
A nice PR is in order by now and could make a big difference.
Thank you, Dudes.
As per company's statement no letter was needed as simple dividend was issued. No ticker , cusip and no value so to show restriction for trade at this time.
The meaningful good news from Rushnet would override the market conditions. We always need good news!!!
This could be a very good news for Medify from his partner:
EMIS enters hospital records market in Canada
EMIS has signed a £1m contract to deliver electronic health records to the University of Calgary's teaching hospital. The contract, which represents EMIS's first in the secondary care sector, will provide electronic health records, laboratory and pathology reporting tools and hospital discharge summaries through EMIS PCS. Sean Riddell, deputy managing director, said: "We are now scaling up to bring similar benefits to the secondary care sector. This has meant adapting the software which is currently designed to meet the generalist approach that is naturally undertaken by family doctors." EMIS Canada will deliver PCS to ten specialist divisions of the university hospital's department of medicine.
From Medify web site:
Owing to the fact that Medify Solutions' technology and products are immediately available, and do require any resource from them, EMIS have agreed a strategy to provide the MedifyRemote Access Solution (MRAS) to their users. This satisfies an obligation on EMIS to supply remote access into the NHS, with no investment in time or cost; conversely, this has been recognised as a value-added revenue opportunity for EMIS. They will actively endorse and market MedifyRemote to all their users, a population of circa 200,000 healthcare professionals.
Solidgold, please no usual sarcasm.
Sherlock
Dudes, and now you finally sing my tune. GOD BLESS AMERICA!!!
Good luck!
"Too big" of achievement for Oracle, I gess. LOL
No, still negative plus negative. LOL
Press Release Source: Medify Solutions Ltd.
Medify Solutions Limited announces Worldwide partnership status with Oracle
Wednesday July 12, 9:45 am ET
TORONTO, July 12 /PRNewswire-FirstCall/ - Remote Technology Company Medify Solutions is delighted to announce its worldwide partnership status with Oracle, the world's largest enterprise software company. The status will associate all Medify Group subsidiaries into the partnership, encompassing the planned group expansion and building on the collaboration.
Jonathan Bryant, Group Executive Chairman of Medify Solutions, said: "I am absolutely delighted in releasing this news which is based on the developments and progress that the company has made. This is a fantastic start to the planned expansion of the company into the global market with news on Europe and the UK to follow."
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Source: Medify Solutions Ltd.